MILESTONE PHARMACEUTICALS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND ANNOUNCES COST-EFFICIENCY MEASURES DESIGNED TO EXTEND CASH RUNWAY THROUGH AFIB-RVR PHASE 3 DATA

Reuters · 1d ago

Please log in to view news